2 documents found, page 1 of 1

Sort by Issue Date
go first page go previous page
go to page: 1
go next page go last page
rss feed search results

Use of putative hepatoprotective agents as an adjunct to anti-TB treatment in E...

Kirakosyan, O; Reimann, M; Andersen, AB; Bjarnason, A; Bakos, Á; Dyrhol-Riise, AM; McLaughlin, AM; Nita, C; Pieridou, D; Chesov, D; Davidavičienė, EV

"Background: Anecdotal information suggests that clinical practice regarding the use of putative hepatoprotective agents in TB treatment varies across countries in the WHO European Region. Methods: Between November 2023 and May 2024, we conducted a standardised questionnaire survey on the use of putative hepatoprotective agents in patients receiving TB treatment among Tuberculosis Network European Trials Group ...

Date: 2025   |   Origin: Repositório Aberto da Universidade do Porto
More info.

Rifapentine access in Europe: growing concerns over key tuberculosis treatment ...

Guglielmetti, L; Günther, G; Leu, C; Cirillo, D; Duarte, R; Garcia-Basteiro, AL; Goletti, D; Jankovic, M; Kuksa, L; Maurer, FP; Méchaï, F; Tiberi, S

[No abstract available]

Date: 2022   |   Origin: Repositório Aberto da Universidade do Porto
More info.
go first page go previous page
go to page: 1
go next page go last page
rss feed search results

2 Results

Queried text

Refine Results

Author





















Date



Document Type



Access rights


Resource